Mark Greenwald to Retrospective Studies
This is a "connection" page, showing publications Mark Greenwald has written about Retrospective Studies.
Connection Strength
0.193
-
Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population. Cancer. 2019 01 15; 125(2):269-277.
Score: 0.064
-
PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
Score: 0.062
-
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
Score: 0.017
-
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
Score: 0.016
-
Visual outcomes after surgery for unilateral cataract in children more than two years old: posterior chamber intraocular lens implantation versus contact lens correction of aphakia. J AAPOS. 1998 Jun; 2(3):168-76.
Score: 0.016
-
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology. 2007 Jul; 114(7):1378-83.
Score: 0.007
-
Rhegmatogenous retinal detachments in children: risk factors and surgical outcomes. Ophthalmology. 2003 Sep; 110(9):1708-13.
Score: 0.006
-
Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr. 1995 Nov; 127(5):718-22.
Score: 0.003
-
Are current pediatric dose recommendations for intravenous theophylline appropriate? J Asthma. 1993; 30(2):109-21.
Score: 0.003